MARKET

TPST

TPST

Tempest Therapeutics Inc
NASDAQ
2.400
+0.170
+7.62%
Pre Market: 2.350 -0.05 -2.08% 05:41 02/09 EST
OPEN
2.209
PREV CLOSE
2.230
HIGH
2.500
LOW
2.209
VOLUME
243
TURNOVER
0
52 WEEK HIGH
12.48
52 WEEK LOW
2.170
MARKET CAP
11.83M
P/E (TTM)
-0.2308
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TPST last week (0202-0206)?
Weekly Report · 1h ago
Tempest Therapeutics Overhauls Leadership and Acquires New Assets
TipRanks · 2d ago
Tempest Therapeutics Inc. Files Initial Statement of Beneficial Ownership for CEO and President Matthew Angel
Reuters · 2d ago
Tempest Therapeutics kündigt Privatplatzierung und unregistrierten Aktienverkauf an
Reuters · 2d ago
Tempest Therapeutics Announces Private Placement of Unregistered Shares
Reuters · 2d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 3d ago
Tempest Therapeutics Closes Acquisition of Dual-Targeting CAR-T Assets
Reuters · 4d ago
Tempest Therapeutics schließt Übernahme von Dual-Targeting CAR-T-Assets ab
Reuters · 4d ago
More
About TPST
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a range of tumors. Its two clinical-stage therapeutic product candidates are Amezalpat and TPST-1495. Amezalpat is an oral, small molecule, selective antagonist of peroxisome proliferator-activated receptor alpha. The ongoing global randomized Phase Ib/II trial of Amezalpat combined with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma. The Company’s second clinical program, TPST-1495, a dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, a pathway implicated in multiple cancers.

Webull offers Tempest Therapeutics Inc stock information, including NASDAQ: TPST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TPST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TPST stock methods without spending real money on the virtual paper trading platform.